Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry

Figure 1

Clinical manifestations in MPO-ANCA-positive and ANCA-negative EGPA subsets. Categorical variables are presented as percentages. Abbreviations: ANCA, anti-neutrophil cytoplasmic antibodies; MPO-ANCA, anti-myeloperoxidase antibodies; and ENT, ear/nose/throat.